Results 181 to 190 of about 65,632 (246)

Therapeutic Implications of ErbB Pathway Modification in Heart Failure with Reduced Ejection Fraction. [PDF]

JACC Basic Transl Sci
Selvaraj S, Felker GM.
europepmc   +1 more source

Exploring the mechanism of Inula japonica Thunb. against non-small cell lung cancer using a computer-aided drug design approach. [PDF]

Medicine (Baltimore)
Qian H, Wang B, Zhang L, Li J, Huang X, Liu B, Zhao Y, Wang M.   +7 more
europepmc   +1 more source

Validation of ancillary procedures on formalin liquid fixed aspiration cytologic samples: from minimum to maximum. [PDF]

Am J Clin Pathol
Rideg O, Dergez T, Tóth A, Tornóczky T, Pavlovics G, Kálmán E.   +5 more
europepmc   +1 more source

Deciphering the anticoccidial mechanism of Qinghao Changshan formula through network pharmacology and molecular docking. [PDF]

Vet World
Tian D, Fu H, Tao H, Li M, Zhang Q, Deng W.   +5 more
europepmc   +1 more source

Switchable Retargeting of Lentiviral Vectors Through a VSV-G-Binding Adapter Molecule. [PDF]

Viruses
Zhuchkov VA, Valikhov MP, Kravchenko YE, Frolova EI, Chumakov SP.   +4 more
europepmc   +1 more source

Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer. [PDF]

Mol Syst Biol
Griffiths JI, Chi F, Farmaki E, Medina EF, Cosgrove PA, Karimi KL, Chen J, Grolmusz VK, Adler FR, Khan QJ, Nath A, Chang JT, Bild AH.   +12 more
europepmc   +1 more source

Advances in immunotherapy and targeted therapy for nasopharyngeal carcinoma: Current progress and combined approaches (Review). [PDF]

Oncol Rep
Yang Z, Liu H, Chen M, Zhang L, Gong M, Yu R.   +5 more
europepmc   +1 more source

From Gefitinib to Amivantamab: Progress and Perspectives of Therapies Targeting the Epidermal Growth Factor Receptor in the Era of Precision Oncology. [PDF]

J Cancer Prev
Liu Z, Kim MO.
europepmc   +1 more source

A remarkable year for NSCLC: Seven new FDA approvals in 2025 across molecular targets. [PDF]

Biomol Biomed
Tomić K, Vranić S.
europepmc   +1 more source

Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic Activity. [PDF]

Antibodies (Basel)
Muzi A, Arriga R, Bulfaro G, Fata F, Costanzo A, Chiarini V, Cappelletti M, Ferrara FF, Bucci F, Montemiglio LC, Savino C, Marra E, Ciliberto G, Aurisicchio L, Vallone B, Roscilli G.   +15 more
europepmc   +1 more source